Advances in adhesive and sealant technology for medical applications are leading to a sharp increase in demand. New methods that make use of advanced sealants and adhesives are rapidly replacing traditional sutures, wires and staples as a less painful and safer option.
Although there are synthetic and semi-synthetic medical adhesives and sealants, biological or natural sealants and adhesives enjoy the largest market share. Fibrin-based products dominate, butgelatin and collagen based sealants and adhesives are rapidly gaining ground.
These sealants and adhesives are most widely used in neurological surgery, but are also used in a range of other surgical processes including cardiovascular surgery, urological surgery and ophthalmic surgery. North America is currently the primary market for surgical adhesives and sealants, but demand in the Asia-Pacific region is the fastest-growing.
A large number of companies are active within this market including Johnson & Johnson, Baxter International Inc., Medtronic PLC,Cohera Medical Inc., Sanofi Group, B. Braun Melsungen AG, C.R. Bard Inc., Vivostat A/S., Ocular Therapeutix Inc., and Cryolife Inc.